vs

Side-by-side financial comparison of Immunovant, Inc. (IMVT) and Stabilis Solutions, Inc. (SLNG). Click either name above to swap in a different company.

Stabilis Solutions, Inc. is the larger business by last-quarter revenue ($13.3M vs $8.4M, roughly 1.6× Immunovant, Inc.). Stabilis Solutions, Inc. runs the higher net margin — -2.0% vs -899.0%, a 897.0% gap on every dollar of revenue. On growth, Immunovant, Inc. posted the faster year-over-year revenue change (140.7% vs -23.3%). Stabilis Solutions, Inc. produced more free cash flow last quarter ($-2.5M vs $-59.8M).

Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative monoclonal antibody therapies for patients with serious, rare autoimmune and inflammatory diseases. Its lead product candidate covers multiple autoimmune indications, with core U.S. operations and a global market expansion strategy.

Stabilis Solutions, Inc. is a leading North American small-scale liquefied natural gas (LNG) producer and distributor. It supplies LNG fuel, cryogenic services, and full-cycle energy solutions to industrial, remote power, transportation, and commercial clients across the United States and Canada, advancing low-emission energy transition efforts.

IMVT vs SLNG — Head-to-Head

Bigger by revenue
SLNG
SLNG
1.6× larger
SLNG
$13.3M
$8.4M
IMVT
Growing faster (revenue YoY)
IMVT
IMVT
+164.0% gap
IMVT
140.7%
-23.3%
SLNG
Higher net margin
SLNG
SLNG
897.0% more per $
SLNG
-2.0%
-899.0%
IMVT
More free cash flow
SLNG
SLNG
$57.4M more FCF
SLNG
$-2.5M
$-59.8M
IMVT

Income Statement — Q4 FY2024 vs Q4 FY2025

Metric
IMVT
IMVT
SLNG
SLNG
Revenue
$8.4M
$13.3M
Net Profit
$-75.3M
$-262.0K
Gross Margin
24.7%
Operating Margin
-896.2%
-2.4%
Net Margin
-899.0%
-2.0%
Revenue YoY
140.7%
-23.3%
Net Profit YoY
-26.7%
-112.4%
EPS (diluted)
$-0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMVT
IMVT
SLNG
SLNG
Q4 25
$13.3M
Q3 25
$20.3M
Q2 25
$17.3M
Q1 25
$17.3M
Q4 24
$17.3M
Q3 24
$17.6M
Q2 24
$18.6M
Q1 24
$8.4M
$19.8M
Net Profit
IMVT
IMVT
SLNG
SLNG
Q4 25
$-262.0K
Q3 25
$1.1M
Q2 25
$-613.0K
Q1 25
$-1.6M
Q4 24
$2.1M
Q3 24
$997.0K
Q2 24
$27.0K
Q1 24
$-75.3M
$1.5M
Gross Margin
IMVT
IMVT
SLNG
SLNG
Q4 25
24.7%
Q3 25
27.6%
Q2 25
26.5%
Q1 25
26.2%
Q4 24
28.5%
Q3 24
28.3%
Q2 24
27.1%
Q1 24
31.6%
Operating Margin
IMVT
IMVT
SLNG
SLNG
Q4 25
-2.4%
Q3 25
5.5%
Q2 25
-2.4%
Q1 25
-9.7%
Q4 24
12.8%
Q3 24
5.0%
Q2 24
2.4%
Q1 24
-896.2%
7.8%
Net Margin
IMVT
IMVT
SLNG
SLNG
Q4 25
-2.0%
Q3 25
5.5%
Q2 25
-3.5%
Q1 25
-9.2%
Q4 24
12.2%
Q3 24
5.7%
Q2 24
0.1%
Q1 24
-899.0%
7.4%
EPS (diluted)
IMVT
IMVT
SLNG
SLNG
Q4 25
Q3 25
$0.06
Q2 25
$-0.03
Q1 25
$-0.09
Q4 24
$0.12
Q3 24
$0.05
Q2 24
$0.00
Q1 24
$-0.50
$0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMVT
IMVT
SLNG
SLNG
Cash + ST InvestmentsLiquidity on hand
$635.4M
$7.5M
Total DebtLower is stronger
$7.9M
Stockholders' EquityBook value
$617.8M
$66.7M
Total Assets
$666.4M
$83.1M
Debt / EquityLower = less leverage
0.12×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMVT
IMVT
SLNG
SLNG
Q4 25
$7.5M
Q3 25
$10.3M
Q2 25
$12.2M
Q1 25
$9.0M
Q4 24
$9.0M
Q3 24
$12.4M
Q2 24
$11.5M
Q1 24
$635.4M
$8.3M
Total Debt
IMVT
IMVT
SLNG
SLNG
Q4 25
$7.9M
Q3 25
$8.3M
Q2 25
$7.6M
Q1 25
$8.3M
Q4 24
$8.9M
Q3 24
$9.3M
Q2 24
$8.6M
Q1 24
$9.1M
Stockholders' Equity
IMVT
IMVT
SLNG
SLNG
Q4 25
$66.7M
Q3 25
$66.7M
Q2 25
$65.5M
Q1 25
$65.9M
Q4 24
$67.0M
Q3 24
$65.4M
Q2 24
$63.7M
Q1 24
$617.8M
$63.2M
Total Assets
IMVT
IMVT
SLNG
SLNG
Q4 25
$83.1M
Q3 25
$87.1M
Q2 25
$83.2M
Q1 25
$83.1M
Q4 24
$85.6M
Q3 24
$89.3M
Q2 24
$82.6M
Q1 24
$666.4M
$80.6M
Debt / Equity
IMVT
IMVT
SLNG
SLNG
Q4 25
0.12×
Q3 25
0.12×
Q2 25
0.12×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.14×
Q2 24
0.13×
Q1 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMVT
IMVT
SLNG
SLNG
Operating Cash FlowLast quarter
$-59.7M
$669.0K
Free Cash FlowOCF − Capex
$-59.8M
$-2.5M
FCF MarginFCF / Revenue
-714.4%
-18.6%
Capex IntensityCapex / Revenue
1.8%
23.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-214.6M
$462.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMVT
IMVT
SLNG
SLNG
Q4 25
$669.0K
Q3 25
$2.4M
Q2 25
$4.5M
Q1 25
$1.0M
Q4 24
$2.2M
Q3 24
$2.6M
Q2 24
$5.0M
Q1 24
$-59.7M
$3.9M
Free Cash Flow
IMVT
IMVT
SLNG
SLNG
Q4 25
$-2.5M
Q3 25
$-1.5M
Q2 25
$3.9M
Q1 25
$538.0K
Q4 24
$-3.4M
Q3 24
$1.2M
Q2 24
$3.7M
Q1 24
$-59.8M
$3.1M
FCF Margin
IMVT
IMVT
SLNG
SLNG
Q4 25
-18.6%
Q3 25
-7.3%
Q2 25
22.4%
Q1 25
3.1%
Q4 24
-19.7%
Q3 24
7.1%
Q2 24
19.7%
Q1 24
-714.4%
15.5%
Capex Intensity
IMVT
IMVT
SLNG
SLNG
Q4 25
23.7%
Q3 25
19.1%
Q2 25
3.7%
Q1 25
2.8%
Q4 24
32.3%
Q3 24
7.4%
Q2 24
7.4%
Q1 24
1.8%
4.4%
Cash Conversion
IMVT
IMVT
SLNG
SLNG
Q4 25
Q3 25
2.14×
Q2 25
Q1 25
Q4 24
1.03×
Q3 24
2.56×
Q2 24
186.59×
Q1 24
2.67×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IMVT
IMVT

Segment breakdown not available.

SLNG
SLNG

Natural Gas Gathering Transportation Marketing And Processing$11.1M84%
Other$1.3M10%
Services$897.0K7%

Related Comparisons